Cargando…

Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study

OBJECTIVE: We evaluated the association of apolipoprotein B (apoB) with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides (TG) in early adulthood with concordant/discordant associations and midlife NAFLD. METHODS: Participants from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Sahil, Wilkins, John T., Ning, Hongyan, Allen, Norrina B., Lewis, Cora E., Carr, J. Jeffrey, Lloyd-Jones, Donald, VanWagner, Lisa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023214/
https://www.ncbi.nlm.nih.gov/pubmed/35462864
http://dx.doi.org/10.1155/2022/1727711
_version_ 1784690289867227136
author Khanna, Sahil
Wilkins, John T.
Ning, Hongyan
Allen, Norrina B.
Lewis, Cora E.
Carr, J. Jeffrey
Lloyd-Jones, Donald
VanWagner, Lisa B.
author_facet Khanna, Sahil
Wilkins, John T.
Ning, Hongyan
Allen, Norrina B.
Lewis, Cora E.
Carr, J. Jeffrey
Lloyd-Jones, Donald
VanWagner, Lisa B.
author_sort Khanna, Sahil
collection PubMed
description OBJECTIVE: We evaluated the association of apolipoprotein B (apoB) with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides (TG) in early adulthood with concordant/discordant associations and midlife NAFLD. METHODS: Participants from the CARDIA study were included (n = 2,655; baseline mean age: 25.0, 59.1% female, and 48.6% black). NAFLD was defined as liver attenuation ≤40 Hounsfield units after excluding other causes of liver fat. Logistic regression models assessed the odds of Y25 NAFLD among tertiles of apoB, LDL-C, non-HDL-C, and TG and quartiles of the apoB/TG ratio. Discordance/concordance analyses examined the association of apoB with each lipid marker and Y25 NAFLD. RESULTS: The Y25 NAFLD prevalence was 10%. The high-tertile TG group (OR 1.87, 95% CI, and 1.30–2.69) and the low- (OR 1.98, 95% CI, and 1.30–3.01) and middle-apoB/TG ratio groups (OR 1.78, 95% CI, and 1.17–2.72) had the greatest odds of midlife NAFLD. Using discordance/concordance analysis, the high-apoB/high-TG group had the highest odds of NAFLD (OR 1.69, 95% CI, and 1.09–2.61) followed by the low-apoB/high-TG group. The high apoB/low TG group had the lowest odds of NAFLD. CONCLUSIONS: Among the studied lipid markers in early adulthood, TG levels have the strongest and most consistent association with midlife NAFLD.
format Online
Article
Text
id pubmed-9023214
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90232142022-04-22 Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Khanna, Sahil Wilkins, John T. Ning, Hongyan Allen, Norrina B. Lewis, Cora E. Carr, J. Jeffrey Lloyd-Jones, Donald VanWagner, Lisa B. J Nutr Metab Research Article OBJECTIVE: We evaluated the association of apolipoprotein B (apoB) with low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides (TG) in early adulthood with concordant/discordant associations and midlife NAFLD. METHODS: Participants from the CARDIA study were included (n = 2,655; baseline mean age: 25.0, 59.1% female, and 48.6% black). NAFLD was defined as liver attenuation ≤40 Hounsfield units after excluding other causes of liver fat. Logistic regression models assessed the odds of Y25 NAFLD among tertiles of apoB, LDL-C, non-HDL-C, and TG and quartiles of the apoB/TG ratio. Discordance/concordance analyses examined the association of apoB with each lipid marker and Y25 NAFLD. RESULTS: The Y25 NAFLD prevalence was 10%. The high-tertile TG group (OR 1.87, 95% CI, and 1.30–2.69) and the low- (OR 1.98, 95% CI, and 1.30–3.01) and middle-apoB/TG ratio groups (OR 1.78, 95% CI, and 1.17–2.72) had the greatest odds of midlife NAFLD. Using discordance/concordance analysis, the high-apoB/high-TG group had the highest odds of NAFLD (OR 1.69, 95% CI, and 1.09–2.61) followed by the low-apoB/high-TG group. The high apoB/low TG group had the lowest odds of NAFLD. CONCLUSIONS: Among the studied lipid markers in early adulthood, TG levels have the strongest and most consistent association with midlife NAFLD. Hindawi 2022-04-14 /pmc/articles/PMC9023214/ /pubmed/35462864 http://dx.doi.org/10.1155/2022/1727711 Text en Copyright © 2022 Sahil Khanna et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Khanna, Sahil
Wilkins, John T.
Ning, Hongyan
Allen, Norrina B.
Lewis, Cora E.
Carr, J. Jeffrey
Lloyd-Jones, Donald
VanWagner, Lisa B.
Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title_full Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title_fullStr Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title_full_unstemmed Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title_short Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
title_sort lipoprotein levels in early adulthood and nafld in midlife: the coronary artery risk development in young adults (cardia) study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023214/
https://www.ncbi.nlm.nih.gov/pubmed/35462864
http://dx.doi.org/10.1155/2022/1727711
work_keys_str_mv AT khannasahil lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT wilkinsjohnt lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT ninghongyan lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT allennorrinab lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT lewiscorae lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT carrjjeffrey lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT lloydjonesdonald lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy
AT vanwagnerlisab lipoproteinlevelsinearlyadulthoodandnafldinmidlifethecoronaryarteryriskdevelopmentinyoungadultscardiastudy